Follow-Up to Gilat: When Will SBS Start Turning Volume Into Profit
The main article showed that SBS pushed Gilat's revenue higher. This follow-up isolates SBS economics and shows that 2025 delivered mostly volume: $126.7 million of revenue, a $10.2 million net loss, a sharp earn-out reset, and a heavy working-capital burden still sitting behind the scale story.
The main article argued that SBS bought Gilat a sharp step-up in scale, but did not resolve the quality-of-profit question. This follow-up isolates that exact issue: not whether Gilat can sell, but when the new IFC engine will start producing acceptable profit instead of mostly producing volume.
In 2025, Gilat got the first half of the story. Commercial revenue jumped 81% to $281.4 million, almost entirely because of SBS. But that segment's gross profit did not rise. It slipped slightly to $74.6 million from $75.3 million, and gross margin fell to 27% from 48%. At the SBS level, the picture is even clearer: from the January 6, 2025 closing date through year-end, SBS contributed $126.7 million of revenue and a $10.2 million net loss, excluding M&A expenses, earn-out fair-value changes, and corporate allocations.
That is the core read. The issue here is not a lack of demand. The issue is that first-production economics are still too weak, and the balance sheet is being asked to finance the bridge period. The earn-out fair value already says expectations were reset lower, and the jump in inventory purchase commitments shows how much working capital still sits behind the scale-up.
Where Profit Is Getting Stuck
| Metric | 2024 | 2025 | What it means |
|---|---|---|---|
| Commercial revenue | $155.3 million | $281.4 million | Up $126.0 million, almost the entire annual increase in the segment |
| Commercial gross profit | $75.3 million | $74.6 million | Gross profit slipped despite the revenue surge |
| Commercial gross margin | 48% | 27% | Scale arrived with a sharp decline in revenue quality |
| SBS revenue since closing | n/a | $126.7 million | Nearly the whole growth engine inside Commercial in 2025 |
| SBS net loss since closing | n/a | $10.2 million | Growth still has not crossed the economics test |
The simplest math here is also the most revealing. Commercial added $126.0 million of revenue in 2025, yet segment gross profit fell by roughly $0.7 million. At the segment level, that means the incremental revenue of 2025 came with almost no gross leverage at all. That does not mean every SBS dollar was gross-loss-making, because the segment figure also carries amortization of acquired intangibles and deal-mix effects. But it does mean that year-one scale did not translate into additional segment gross profit.
The filing says that the gross-margin decline in Commercial was mainly driven by SBS, because SBS had lower gross margins during its initial production periods and because the segment absorbed amortization of acquired intangibles. That wording matters. The bottleneck is not only accounting. It is also about stage. When production is still in its early ramp, high volume does not guarantee profit. It can just as easily load cost, execution risk, and inventory needs before the operating curve settles down.
That leads to the key distinction for the next few quarters. In 2025, Gilat proved there is a market and that it can push SBS into large revenue numbers. It did not yet prove that those numbers arrive on terms that generate acceptable net profit.
The Earn-Out Already Signals a Reset in Expectations
The total estimated SBS purchase price was $139.0 million. Inside that amount sat an earn-out initially recorded at a fair value of $31.2 million, while the contractual cash earn-out can reach up to $147 million if the performance milestones are met. By year-end 2025, the fair value of that earn-out had already fallen to $7.7 million.
This is not small accounting noise. The company explains that the earn-out fair value is driven by the probability of achieving the performance milestones. So a 75% decline in the first year is effectively a signal that the original path now looks materially less likely, or at least materially less near-term and less certain. In other words, even without a blunt management sentence saying expectations disappointed, the valuation model already reflects a reset.
There is another point embedded here. Changes in earn-out fair value run through Other operating income, net. So in the same year when SBS generated a stand-alone net loss, the fall in the earn-out liability also provided some accounting relief higher up the income statement. That does not invalidate the acquisition. It does mean that part of the reported operating relief in 2025 came from remeasurement, not from proven improvement in the business economics.
Working Capital: The Real Strain Sits Beyond the Inventory Line
Anyone looking only at the inventory line can miss the bigger burden. Inventories ended 2025 at $45.4 million, up from $38.9 million. That is meaningful, but it is not the main pressure point. The bigger issue is inventory purchase commitments: $164.3 million at the end of 2025 versus $31.0 million a year earlier. Of that 2025 total, $141.2 million was with sole-source or limited-number suppliers, up from $24.7 million in 2024.
That gap is exactly what makes the SBS story uncomfortable. The balance sheet shows only part of the effort. The commitments note shows how much material, component, and supplier capacity Gilat has already committed in order to support the volume. So even if booked inventory did not explode, the economic obligation did. And the higher the supplier concentration, the tighter the room to maneuver.
The point becomes sharper when it is tied back to the acquisition itself. When SBS entered the balance sheet, it brought $53.7 million of advances from customers and deferred revenue, against only $3.6 million of trade receivables and contract assets and $10.4 million of inventory. So SBS did not arrive as a business with no demand and no customer funding. Quite the opposite, it arrived with a meaningful base of prepaid business. That matters because it says the 2025 problem is not missing orders or missing customer pre-funding.
And yet the consolidated cash picture still shows pressure. Trade receivables rose by $36.3 million, contract assets rose by $12.0 million, and the company explicitly says the increase in contract assets came from revenue recognized in excess of billings. Advances from customers and deferred revenue also rose sharply, by $59.9 million, and the filing explicitly links that increase to SBS. But that still does not change the broader point: scale is requiring more components, more production support, and more working capital before delivery. That is exactly why the filing also warns explicitly that SBS is expected to continue requiring significant working capital.
The critical read-through is not just that commitments increased. It is that they increased before the margin case was proven. That makes SBS a growth engine that still consumes confidence, capacity, and cash almost as fast as it creates revenue.
Demand Is Real, but It Still Does Not Answer the Question
This is where the January 20, 2026 6-K matters. Gilat announced an approximately $11 million SkyEdge platform order from a leading satellite operator in Asia Pacific, with deliveries expected over the next 12 months. That is a positive data point. It says Commercial order flow did not disappear after year-end, and customers are still buying platforms for advanced VHTS applications.
But that still does not solve the SBS question. The order proves continuing commercial demand. It does not prove that the terminal layer brought in through SBS has already moved past the low-margin initial-production stage. That distinction matters because it is very easy to read another order headline and assume the problem is fixed. It is not. For the SBS thesis to improve materially, the evidence has to show up not only in more Commercial orders, but in better gross margin, a smaller stand-alone SBS loss, and a calmer relationship between purchase commitments and recognized revenue.
What Has to Happen Now
2026 still looks like a proof year here, not a victory year. For SBS to start justifying the volume Gilat bought at a high price, three things need to happen together:
| What has to show up | Why it matters |
|---|---|
| Commercial gross margin recovery | Without it, volume stays just volume |
| Clear shrinkage in the SBS stand-alone loss | That is the proof that early production is no longer eating the value |
| Slower growth, or stabilization, in inventory commitments relative to recognized revenue | Otherwise working capital will keep absorbing too much of the payoff |
If those three signals show up together, then 2025 can be read as an expensive but one-time bridge year. If they do not, SBS may continue to hold up Gilat's revenue line while remaining a business that drags on margin, balance-sheet flexibility, and cash needs.
Conclusion
SBS has already proved that it can bring volume. It has not yet proved that the volume is worth the purchase price booked in the deal and the working-capital load required to support it. The sharpest datapoint here is not only the $10.2 million loss. It is the combination of a crushed Commercial margin, an earn-out marked down aggressively, and purchase commitments that expanded much faster than the inventory line on the balance sheet.
That is the issue the market will have to measure in the next few quarters. Not whether Commercial stays busy, but whether SBS stops consuming so much economics just to sustain that activity level.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.